Implantable Defibrillators Market Increasing Demand for Efficient Management Practices Report Till 2027

Rise in the incidence of heart disorders and advancement in the technology such as S-ICDs developed as an alternative to conventional T-ICDs with less potential hazards drive the market growth.

Implantable defibrillators are used to prevent sudden death in patients who sustained atrial fibrillation or ventricular tachycardia. These devices are implanted inside the patients body and are able to perform defibrillation, pacing of the heart, and cardioversion. The irregular heart rhythms that require ICD implant include bradycardia, ventricular tachycardia, and ventricular fibrillation.

Surge in geriatric population; increase in prevalence of chronic health conditions such as cardiac arrhythmia, ventricular fibrillation, and pulseless ventricular tachycardia, growth in preference for S-ICDs, and rise in in awareness among patients about implantable defibrillators are expected to drive the market growth. However, lack of awareness towards the availability of implantable defibrillator to prevent sudden cardiac arrest (SCA) and adoption of these devices in low- and middle-income economies are projected to hamper the market growth.

Download Report Sample:

The demand for implantable defibrillators is expected to increase globally during the forecast period due to rapid increase in geriatric population and rise in incidence of sudden cardiac arrest (SCA). However, factors such as lack of awareness towards the advantage of using implantable defibrillators, high cost of implantable defibrillators, and unfavorable reimbursement policies are anticipated to hamper the market growth. Rise in demand for ICDs for patients with nonischemic cardiomyopathy reduces the risk of mortality to about 23%, which is expected to offer new opportunities for the market players.

Transvenous implantable cardioverter-defibrillator (T-ICDs) segment dominated the global market in 2015, in terms of value, and is expected to maintain this trend throughout the analysis period. T-ICDs are the most commonly for the treatment of heart disorders for higher precision and targeted functioning. However, in terms of volume, CRT-D is projected to lead the market, reaching 1,127 thousand units by 2022, registering a CAGR of 8.9%.

Key Benefits:-

- This report provides an extensive analysis of the current & emerging market trends and dynamics in the global implantable defibrillators market.

- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.

- This report entails the detailed quantitative analysis of the current trends and future estimations to identify the prevailing opportunities.

- Comprehensive analysis of factors that drive and restrict the market growth is provided in the report.

- Region- and country-wise market conditions are analyzed in the report.

North America led the global market, and is expected to maintain its dominance during the forecast period. This is attributed to the rise in incidence of sudden cardiac arrest (SCA), increase in adoption of S-ICDs, high purchasing power, and availability of advanced healthcare facilities.

Inquiry for Buying:

The key players operating in the global implantable defibrillators market include Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., St. Jude Medical, Inc., Biotronik Se & Co.KG, and Sorin Group.

Contact Info:
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Phone: 18007925285

Release ID: 89032860